Скачать или смотреть Clonal tracking for patients at risk of developing therapy-related myeloid neoplasms

Koichi Takahashi, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, comments on the integration of clonal tracking into clinical decision-making for patients at risk of developing therapy-related myeloid neoplasms, to provide detailed insights into clonal evolution. He suggests that with the right molecular pathologist and educational efforts, clinicians can effectively interpret and utilize these results, but acknowledges that overwhelming physicians with data is a potential concern. This interview took place at the 7th International Workshop on Acute Leukemias (iwAL 2025), held in Washington, DC.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.